Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Approximately one-third of patients with Huntington’s disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD,…
A new study from the Radiological Society of North America reveals that changes in the visual system of patients diagnosed with Parkinson’s disease may provide important biomarkers for early detection…
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These findings may explain the causes of the debilitating symptoms and…
Emily Ruether, MD, has built a career around the treatment of movement disorders. In this video, she discusses her approach to helping patients with certain conditions resume the…
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
